|
1
|
Leff SE, Rosenfeld MG and Evans RM:
Complex transcriptional units: Diversity in gene expression by
alternative RNA processing. Annu Rev Biochem. 55:1091–1117. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan Q, Shai O, Lee LJ, Frey BJ and
Blencowe BJ: Deep surveying of alternative splicing complexity in
the human transcriptome by high-throughput sequencing. Nat Genet.
40:1413–1415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Black DL: Mechanisms of alternative
pre-messenger RNA splicing. Annu Rev Biochem. 72:291–336. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matlin AJ, Clark F and Smith CW:
Understanding alternative splicing: Towards a cellular code. Nat
Rev Mol Cell Biol. 6:386–398. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sammeth M, Foissac S and Guigó R: A
general definition and nomenclature for alternative splicing
events. PLOS Comput Biol. 4:e10001472008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
David CJ and Manley JL: Alternative
pre-mRNA splicing regulation in cancer: Pathways and programs
unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oltean S and Bates DO: Hallmarks of
alternative splicing in cancer. Oncogene. 33:5311–5318. 2014.
View Article : Google Scholar
|
|
8
|
Kim E, Goren A and Ast G: Insights into
the connection between cancer and alternative splicing. Trends
Genet. 24:7–10. 2008. View Article : Google Scholar
|
|
9
|
Fackenthal JD and Godley LA: Aberrant RNA
splicing and its functional consequences in cancer cells. Dis Model
Mech. 1:37–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miura K, Fujibuchi W and Unno M: Splice
isoforms as therapeutic targets for colorectal cancer.
Carcinogenesis. 33:2311–2319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thorsen K, Sørensen KD, Brems-Eskildsen
AS, Modin C, Gaustadnes M, Hein AM, Kruhøffer M, Laurberg S, Borre
M, Wang K, et al: Alternative splicing in colon, bladder, and
prostate cancer identified by exon array analysis. Mol Cell
Proteomics. 7:1214–1224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mojica W and Hawthorn L: Normal colon
epithelium: A dataset for the analysis of gene expression and
alternative splicing events in colon disease. BMC Genomics.
11:52010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gardina PJ, Clark TA, Shimada B, Staples
MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, et al:
Alternative splicing and differential gene expression in colon
cancer detected by a whole genome exon array. BMC Genomics.
7:3252006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bisognin A, Pizzini S, Perilli L, Esposito
G, Mocellin S, Nitti D, Zanovello P, Bortoluzzi S and Mandruzzato
S: An integrative framework identifies alternative splicing events
in colorectal cancer development. Mol Oncol. 8:129–141. 2014.
View Article : Google Scholar
|
|
15
|
Thorsen K, Mansilla F, Schepeler T, Øster
B, Rasmussen MH, Dyrskjøt L, Karni R, Akerman M, Krainer AR,
Laurberg S, et al: Alternative splicing of SLC39A14 in colorectal
cancer is regulated by the Wnt pathway. Mol Cell Proteomics.
10:M110.0029982011. View Article : Google Scholar :
|
|
16
|
Gantt GA, Chen Y, Dejulius K, Mace AG,
Barnholtz-Sloan J and Kalady MF: Gene expression profile is
associated with chemo-radiation resistance in rectal cancer.
Colorectal Dis. 16:57–66. 2014. View Article : Google Scholar
|
|
17
|
Kim Y, Joo KM, Jin J and Nam DH: Cancer
stem cells and their mechanism of chemo-radiation resistance. Int J
Stem Cells. 2:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hiro J, Inoue Y, Toiyama Y, Miki C and
Kusunoki M: Mechanism of resistance to chemoradiation in p53 mutant
human colon cancer. Int J Oncol. 32:1305–1310. 2008.PubMed/NCBI
|
|
19
|
Trapnell C, Pachter L and Salzberg SL:
TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics.
25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trapnell C, Roberts A, Goff L, Pertea G,
Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katz Y, Wang ET, Airoldi EM and Burge CB:
Analysis and design of RNA sequencing experiments for identifying
isoform regulation. Nat Methods. 7:1009–1015. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu G, Li F, Qin Y, Bo X, Wu Y and Wang S:
GOSemSim: An R package for measuring semantic similarity among GO
terms and gene products. Bioinformatics. 26:976–978. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grosso AR, Martins S and Carmo-Fonseca M:
The emerging role of splicing factors in cancer. EMBO Rep.
9:1087–1093. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Narla G, DiFeo A, Yao S, Banno A, Hod E,
Reeves HL, Qiao RF, Camacho-Vanegas O, Levine A, Kirschenbaum A, et
al: Targeted inhibition of the KLF6 splice variant, KLF6 SV1,
suppresses prostate cancer cell growth and spread. Cancer Res.
65:5761–5768. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Venables JP, Klinck R, Koh C, Gervais-Bird
J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe
E, et al: Cancer-associated regulation of alternative splicing. Nat
Struct Mol Biol. 16:670–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wielenga VJ, Heider KH, Offerhaus GJ,
Adolf GR, van den Berg FM, Ponta H, Herrlich P and Pals ST:
Expression of CD44 variant proteins in human colorectal cancer is
related to tumor progression. Cancer Res. 53:4754–4756.
1993.PubMed/NCBI
|
|
28
|
Mulder JW, Kruyt PM, Sewnath M, Oosting J,
Seldenrijk CA, Weidema WF, Offerhaus GJ and Pals ST: Colorectal
cancer prognosis and expression of exon-v6-containing CD44
proteins. Lancet. 344:1470–1472. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herrlich P, Pals S and Ponta H: CD44 in
colon cancer. Eur J Cancer. 31A:1110–1112. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bilchik AJ, Poston G, Curley SA, Strasberg
S, Saltz L, Adam R, Nordlinger B, Rougier P and Rosen LS:
Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary
note. J Clin Oncol. 23:9073–9078. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okonkwo A, Musunuri S, Talamonti M, Benson
A III, Small W Jr, Stryker SJ and Rao MS: Molecular markers and
prediction of response to chemoradiation in rectal cancer. Oncol.
8:497–500. 2001.
|
